Abstract
Administration of high doses (> 1000 Mg) of iron isomaltoside in chronic kidney disease patients with iron deficiency anaemia gives an effective increase in haemoglobin without additional safety concerns
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
